Showing 1,821 - 1,840 results of 140,567 for search '(( 10 ((we decrease) OR (mean decrease)) ) OR ( 50 ((ng decrease) OR (a decrease)) ))', query time: 1.62s Refine Results
  1. 1821
  2. 1822

    Rhinorrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”
  3. 1823

    Vomit-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”
  4. 1824

    Symptoms free-days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”
  5. 1825

    Diarrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”
  6. 1826

    Nausea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”
  7. 1827

    Cough-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”
  8. 1828

    Dyspnea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…”
  9. 1829
  10. 1830
  11. 1831
  12. 1832

    Decreased macrophage recruitment correlates with decreased angiogenesis. by Johanna R. Reed (306158)

    Published 2013
    “…<p>A) Quantification of BrdU incorporation demonstrates that decreased macrophage infiltration does not significantly correlate with a change in epithelial cell proliferation (N.S. = not significant). …”
  13. 1833
  14. 1834
  15. 1835
  16. 1836
  17. 1837

    Taurolidine lock solution for catheter-related bloodstream infections in pediatric patients: A meta-analysis by Yan Sun (22436)

    Published 2020
    “…The number of catheters removed due to infection or suspected infection was not significantly different between the two groups (RR: 0.68; 95% CI:0.22, 2.10; I<sup>2</sup> = 56%; P = 0.50) (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0231110#pone.0231110.g005" target="_blank">Fig 5</a>). …”
  18. 1838
  19. 1839
  20. 1840